BIIB

Biogen Inc. Common Stock

$196.00 -0.20%

Recent alerts on BIIB

All signals →

News Biogen, UCB lupus drug dapirolizumab pegol meets phase 3 goal

News Biogen faces Italian antitrust probe over rivalry with Sandoz for MS drugs

News Biogen Stock Slides After Trial Miss, but Analysts Stay Bullish

News Biogen, Denali to drop Parkinson’s therapy after mid-stage trial setback

News Biogen Stock Pops After FDA Approves New High-Dose Spinraza For Spinal Muscular Atrophy

News Biogen Lands Two Fast-Growing Drugs In Blockbuster Apellis Deal

News Trump Signals Iran Exit, S&P 500 Heads For Worst Month Since September 2022: What's Moving The Market On Tuesday?

News Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy

News 6 Healthcare Stocks Positioned to Soar After Trump-Pfizer Deal

News Biogen's $85 Million Deal Could Change How Patients Get Spinraza Treatment

News FDA Tightens Safety Guidelines For Biogen Leqembi Alzheimer's Therapy

News Biogen Lifts Outlook As Rare Disease And Alzheimer's Drug Sales Accelerate

News Biogen Beats Q1 Earnings Expectations As Two Newcomer Drug Sales Spike, Avoids Tariff Impact

News Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy

News Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed

News NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects

News Alzheimer's Drugs From Eli Lilly And Biogen Still Deemed Too Costly For NHS Funding

News US Stocks Set For A Cautious Start Ahead Of Inflation Data: Expert Says 'Strong Bull Markets Tend To Roar Back To Life After Corrections'

News Leqembi And Skyclarys Expected To Drive Biogen's Future Growth: Analysts

News Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok

News Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma

News These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024

News Biogen Bid For Sage Therapeutics Could Strengthen Neurology Strategy: Analysts

News FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi

News Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026

Get push alerts for BIIB

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS